Symbiotec Pharmalab Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Financial Year | Jun '26 | ||
|---|---|---|---|
Total Qtr Revenue cr | 218.49 | ||
| Other Income Qtr Cr | 0.34 | ||
| Operating Revenues Qtr | 218.15 | ||
Loading chart... | |||
Operating Expenses Qtr | 172.95 | ||
Operating Profit Qtr | 45.20 | ||
EBITDA Qtr Cr | 45.54 | ||
Depreciation Qtr | 21.82 | ||
Net Profit Qtr | 14.06 | ||
Basic EPS Qtr | 2.24 | ||